192 related articles for article (PubMed ID: 3308207)
1. Experimental autoimmune myositis in SJL/J mice.
Rosenberg NL; Ringel SP; Kotzin BL
Clin Exp Immunol; 1987 Apr; 68(1):117-29. PubMed ID: 3308207
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of class II MHC antigens by skeletal muscle endothelial cells in experimental autoimmune myositis.
Rosenberg NL; Kotzin BL
J Immunol; 1989 Jun; 142(12):4289-94. PubMed ID: 2656863
[TBL] [Abstract][Full Text] [Related]
3. Experimental autoimmune myositis in SJL/J mice produced by immunization with syngeneic myosin B fraction. Transfer by both immunoglobulin G and T cells.
Matsubara S; Okumura S
J Neurol Sci; 1996 Dec; 144(1-2):171-5. PubMed ID: 8994120
[TBL] [Abstract][Full Text] [Related]
4. Experimental allergic myositis in SJL/J mice immunized with rabbit myosin B fraction: immunohistochemical analysis and transfer.
Matsubara S; Shima T; Takamori M
Acta Neuropathol; 1993; 85(2):138-44. PubMed ID: 8442405
[TBL] [Abstract][Full Text] [Related]
5. Experimental autoimmune inflammatory myopathy.
Hart MN; Linthicum DS; Waldschmidt MM; Tassell SK; Schelper RL; Robinson RA
J Neuropathol Exp Neurol; 1987 Sep; 46(5):511-21. PubMed ID: 3625232
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin prevents experimental autoimmune myositis in SJL mice by reducing anti-myosin antibody and by blocking complement deposition.
Wada J; Shintani N; Kikutani K; Nakae T; Yamauchi T; Takechi K
Clin Exp Immunol; 2001 May; 124(2):282-9. PubMed ID: 11422206
[TBL] [Abstract][Full Text] [Related]
7. In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis.
Neumann DA; Lane JR; Wulff SM; Allen GS; LaFond-Walker A; Herskowitz A; Rose NR
J Immunol; 1992 Jun; 148(12):3806-13. PubMed ID: 1602130
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholine receptor and thymus in experimental autoimmune myasthenia gravis and experimental myositis.
Ueno S; Wada K; Kang J; Takahashi M; Tarui S
Clin Exp Immunol; 1982 Dec; 50(3):563-71. PubMed ID: 7165999
[TBL] [Abstract][Full Text] [Related]
9. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.
Nagaraju K; Raben N; Loeffler L; Parker T; Rochon PJ; Lee E; Danning C; Wada R; Thompson C; Bahtiyar G; Craft J; Hooft Van Huijsduijnen R; Plotz P
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9209-14. PubMed ID: 10922072
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies: a primary role of complement in autoimmune cell damage.
Morgan BP; Sewry CA; Siddle K; Luzio JP; Campbell AK
Immunology; 1984 May; 52(1):181-8. PubMed ID: 6370840
[TBL] [Abstract][Full Text] [Related]
11. Studies on the structure of complement C3 and the stability of C3 derived phagocytic ligands C3b/iC3b in SJL/J and BALB/c mice.
Lynch DM; Kay PH; Papadimitriou JM; Grounds MD
Eur J Immunogenet; 1993 Feb; 20(1):1-9. PubMed ID: 8443150
[TBL] [Abstract][Full Text] [Related]
12. Experimental myasthenia gravis, myositis and myocarditis in guinea-pigs immunized with subcellular fractions of calf thymus or calf skeletal muscle in Freund's complete adjuvant.
Kalden JR; Williamson WG; Irvine WJ
Clin Exp Immunol; 1973 Jan; 13(1):79-88. PubMed ID: 4357982
[TBL] [Abstract][Full Text] [Related]
13. FK506 suppressed the inflammatory change of EAM in SJL/J mice.
Nemoto H; Nemoto K; Sugimoto H; Kinoshita M
J Neurol Sci; 2001 Dec; 193(1):7-11. PubMed ID: 11718743
[TBL] [Abstract][Full Text] [Related]
14. Development of an improved animal model of experimental autoimmune myositis.
Kang J; Zhang HY; Feng GD; Feng DY; Jia HG
Int J Clin Exp Pathol; 2015; 8(11):14457-64. PubMed ID: 26823763
[TBL] [Abstract][Full Text] [Related]
15. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
Cantaert T; Teitsma C; Tak PP; Baeten D
Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
[TBL] [Abstract][Full Text] [Related]
16. Adoptive transfer of experimental autoimmune dacryoadenitis in susceptible and resistant mice.
Liu SH; Zhou DH; Hess AD
Cell Immunol; 1993 Sep; 150(2):311-20. PubMed ID: 8370074
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of Murine Experimental Autoimmune Myositis by Toll-Like Receptor 7/8.
Sciorati C; Monno A; Doglio MG; Rigamonti E; Ascherman DP; Manfredi AA; Rovere-Querini P
Arthritis Rheumatol; 2018 Aug; 70(8):1276-1287. PubMed ID: 29569859
[TBL] [Abstract][Full Text] [Related]
18. Experimental allergic myositis in rats.
Morgan G; Peter JB; Newbould BB
Arthritis Rheum; 1971; 14(5):599-609. PubMed ID: 5094562
[No Abstract] [Full Text] [Related]
19. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
[TBL] [Abstract][Full Text] [Related]
20. The time course of basic fibroblast growth factor expression in crush-injured skeletal muscles of SJL/J and BALB/c mice.
Anderson JE; Mitchell CM; McGeachie JK; Grounds MD
Exp Cell Res; 1995 Feb; 216(2):325-34. PubMed ID: 7843277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
